787 related articles for article (PubMed ID: 22986593)
1. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
[TBL] [Abstract][Full Text] [Related]
2. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
[TBL] [Abstract][Full Text] [Related]
3. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
[TBL] [Abstract][Full Text] [Related]
4. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice.
Siddiq F; Chaudhry SA; Khatri R; Rodriguez GJ; Tummala R; Suri MF; Qureshi AI
Neurosurgery; 2012 Jul; 71(1):68-73. PubMed ID: 22382209
[TBL] [Abstract][Full Text] [Related]
5. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
[TBL] [Abstract][Full Text] [Related]
6. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.
Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N
Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316
[TBL] [Abstract][Full Text] [Related]
7. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
[TBL] [Abstract][Full Text] [Related]
8. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
[TBL] [Abstract][Full Text] [Related]
9. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.
Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI
Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591
[TBL] [Abstract][Full Text] [Related]
10. Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology.
Yu SC; Cheng HK; Cheng PW; Lui WM; Leung KM; Tan CB; Pang KY; Wong GK; Cheung YL; Lee R; Wong YC; Wong CK; Kwok JC;
Hong Kong Med J; 2013 Feb; 19(1):69-73. PubMed ID: 23378358
[TBL] [Abstract][Full Text] [Related]
11. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).
Fiorella D; Derdeyn CP; Lynn MJ; Barnwell SL; Hoh BL; Levy EI; Harrigan MR; Klucznik RP; McDougall CG; Pride GL; Zaidat OO; Lutsep HL; Waters MF; Hourihane JM; Alexandrov AV; Chiu D; Clark JM; Johnson MD; Torbey MT; Rumboldt Z; Cloft HJ; Turan TN; Lane BF; Janis LS; Chimowitz MI;
Stroke; 2012 Oct; 43(10):2682-8. PubMed ID: 22984008
[TBL] [Abstract][Full Text] [Related]
12. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
[TBL] [Abstract][Full Text] [Related]
13. Safety of angioplasty and stenting without thrombolysis for the treatment of early ischemic stroke.
Abou-Chebl A; Vora N; Yadav JS
J Neuroimaging; 2009 Apr; 19(2):139-43. PubMed ID: 18826443
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of carotid artery stenting in high-risk patients with carotid artery stenosis: a single neurovascular center retrospective review of 101 consecutive patients.
Meyer SA; Gandhi CD; Johnson DM; Winn HR; Patel AB
Neurosurgery; 2010 Mar; 66(3):448-53; discussion 453-4. PubMed ID: 20124935
[TBL] [Abstract][Full Text] [Related]
15. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.
Fiorella D; Turan TN; Derdeyn CP; Chimowitz MI
J Neurointerv Surg; 2009 Jul; 1(1):35-9. PubMed ID: 21994103
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.
Tarlov N; Jahan R; Saver JL; Sayre JW; Ali LK; Kim D; Duckwiler GR; Tateshima S; Viñuela F; Liebeskind DS
J Neurointerv Surg; 2012 Jan; 4(1):34-9. PubMed ID: 21990460
[TBL] [Abstract][Full Text] [Related]
17. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ;
Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957
[TBL] [Abstract][Full Text] [Related]
18. Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure.
Samaniego EA; Tari-Capone F; Linfante I; Silva CF; Spilberg G; Gounis M; Wakhloo AK; Dabus G
J Neurointerv Surg; 2013 Jul; 5(4):302-5. PubMed ID: 22544819
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural risk and long-term outcome of intracranial angioplasty based on a single-centre experience.
Krajíčková D; Krajina A; Lojík M; Mulačová M; Vališ M
Vasa; 2013 Jul; 42(4):264-74. PubMed ID: 23823858
[TBL] [Abstract][Full Text] [Related]
20. Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
Marks MP
Stroke; 2012 Feb; 43(2):580-4. PubMed ID: 22246690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
